$1.66
0.085.06%
al cierre: -
$1.64
-0.02-1.20%
After hour: 7:11 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Protalix BioTherapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 13
Estimación de BPA
$0.070
Estimación de ingresos trimestrales
$17.79M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$61.95M
Analice el historial de beneficios de Protalix BioTherapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
PLX | Protalix BioTherapeutics | $0.03 | $0.07 | — | — | $17.96M | $17.79M | — | — | 11/13/2025 | |
PLX | Protalix BioTherapeutics | -$0.03 | $0.03 | $0.00 | -100.00% | $13.47M | $13.55M | $15.66M | 15.89% | 08/14/2025 | |
PLX | Protalix BioTherapeutics | -$0.06 | $0.03 | -$0.05 | -162.50% | $3.75M | $21.60M | $10.11M | -53.18% | 05/09/2025 | |
PLX | Protalix BioTherapeutics | -$0.07 | $0.03 | $0.09 | 28.57% | $10.49M | $21.60M | $18.22M | -2.89% | 03/17/2025 | |
PLX | Protalix BioTherapeutics | -$0.04 | $0.04 | $0.03 | -50.00% | $10.35M | $16.26M | $17.96M | 10.45% | 11/14/2024 | |
PLX | Protalix BioTherapeutics | $0.21 | $0.02 | -$0.03 | -250.00% | $35.08M | $12.50M | $13.47M | 7.79% | 08/14/2024 | |
PLX | Protalix BioTherapeutics | -$0.05 | -$0.02 | -$0.06 | -200.00% | $9.59M | $9.20M | $3.75M | -59.26% | 05/10/2024 | |
PLX | Protalix BioTherapeutics | -$0.07 | -$0.03 | -$0.07 | -133.33% | $8.62M | $5.80M | $10.49M | 80.79% | 03/14/2024 | |
PLX | Protalix BioTherapeutics | -$0.07 | -$0.04 | -$0.04 | 0.00% | $14.18M | $10.00M | $10.35M | 3.45% | 11/06/2023 | |
PLX | Protalix BioTherapeutics | -$0.11 | -$0.04 | $0.21 | 625.00% | $8.75M | $10.22M | $35.08M | 243.20% | 08/07/2023 | |
PLX | Protalix BioTherapeutics | -$0.05 | — | -$0.05 | — | $16.09M | — | $9.59M | — | 05/04/2023 | |
PLX | Protalix BioTherapeutics | -$0.14 | -$0.15 | -$0.07 | 53.33% | $8.55M | $6.12M | $8.62M | 40.80% | 02/27/2023 | |
PLX | Protalix BioTherapeutics | -$0.09 | -$0.15 | -$0.07 | 53.33% | $12.05M | $14.18M | $14.18M | 0.00% | 11/14/2022 | |
PLX | Protalix BioTherapeutics | -$0.25 | -$0.18 | -$0.11 | 38.89% | $6.43M | — | $8.75M | — | 08/15/2022 | |
PLX | Protalix BioTherapeutics | -$0.14 | -$0.05 | -$0.05 | 0.00% | $11.32M | $15.50M | $16.09M | 3.77% | 05/16/2022 | |
PLX | Protalix BioTherapeutics | $0.03 | -$0.11 | -$0.14 | -27.27% | $19.50M | $7.79M | $8.55M | 9.74% | 03/31/2022 | |
PLX | Protalix BioTherapeutics | -$0.14 | -$0.11 | -$0.09 | 18.18% | $10.79M | $7.79M | $12.05M | 54.74% | 11/15/2021 | |
PLX | Protalix BioTherapeutics | -$0.13 | -$0.08 | -$0.25 | -212.50% | $10.97M | $8.30M | $6.43M | -22.57% | 08/16/2021 | |
PLX | Protalix BioTherapeutics | $0.10 | -$0.17 | -$0.14 | 17.65% | $21.65M | $10.95M | $11.32M | 3.38% | 05/14/2021 | |
PLX | Protalix BioTherapeutics | $0.02 | -$0.08 | $0.03 | 137.50% | $3.78M | $11.99M | $19.50M | 62.59% | 03/30/2021 | |
PLX | Protalix BioTherapeutics | -$0.20 | -$0.17 | -$0.14 | 17.65% | $14.25M | $10.08M | $10.79M | 7.04% | 10/29/2020 |
Protalix BioTherapeutics (PLX) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $0 | $0.03 | -100.0 % |
| Q1 | 2025-05-09 | $-0.05 | $0.03 | -162.5 % |
| Q4 | 2025-03-17 | $0.09 | $0.03 | 28.6 % |
| Q3 | 2024-11-14 | $0.03 | $0.04 | -50.0 % |
Protalix BioTherapeutics (PLX) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $15.66M | $13.55M | 15.9 % |
| Q1 | 2025-05-09 | $10.11M | $21.60M | -53.2 % |
| Q4 | 2025-03-17 | $18.22M | $21.60M | -2.89 % |
| Q3 | 2024-11-14 | $17.96M | $16.26M | 10.4 % |
PREGUNTAS FRECUENTES
¿Cuándo Protalix BioTherapeutics (AMEX:PLX) publicará los resultados?
Está previsto que Protalix BioTherapeutics (PLX) presente resultados el noviembre 13, 2025. Los últimos resultados se publicaron el agosto 14, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Protalix BioTherapeutics (AMEX:PLX)?
El BPA real fue de $0.00, que no alcanzó la estimación de $0.03.
¿Cuáles fueron los ingresos de Protalix BioTherapeutics (AMEX:PLX)?
Los ingresos reales fueron $15.7M, que superó la estimación de $13.5M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.